Business Description
SMO Clinplus Co Ltd
ISIN : CNE100005CP8
Share Class Description:
SZSE:301257: Class ACompare
Compare
Traded in other countries / regions
301257.China IPO Date
2022-05-17Description
SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 119.02 | |||||
| Equity-to-Asset | 0.83 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.06 | |||||
| Interest Coverage | 247.97 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 7.9 | |||||
| Beneish M-Score | -2.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18.6 | |||||
| 3-Year EBITDA Growth Rate | 37.1 | |||||
| 3-Year EPS without NRI Growth Rate | 29.4 | |||||
| 3-Year FCF Growth Rate | 61.3 | |||||
| 3-Year Book Growth Rate | 68.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 17.87 | |||||
| Future 3-5Y Total Revenue Growth Rate | 14.48 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.35 | |||||
| 9-Day RSI | 32.34 | |||||
| 14-Day RSI | 38.94 | |||||
| 6-1 Month Momentum % | 9.36 | |||||
| 12-1 Month Momentum % | -35.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.62 | |||||
| Quick Ratio | 5.62 | |||||
| Cash Ratio | 3.67 | |||||
| Days Sales Outstanding | 56.68 | |||||
| Days Payable | 2.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.96 | |||||
| Dividend Payout Ratio | 0.13 | |||||
| Forward Dividend Yield % | 1.15 | |||||
| 5-Year Yield-on-Cost % | 0.98 | |||||
| 3-Year Average Share Buyback Ratio | -10.8 | |||||
| Shareholder Yield % | 0.84 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 26.17 | |||||
| Operating Margin % | 14.73 | |||||
| Net Margin % | 13.1 | |||||
| FCF Margin % | -0.65 | |||||
| ROE % | 9.64 | |||||
| ROA % | 7.79 | |||||
| ROIC % | 27.19 | |||||
| ROC (Joel Greenblatt) % | 638.69 | |||||
| ROCE % | 11.42 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.91 | |||||
| Forward PE Ratio | 15.18 | |||||
| PE Ratio without NRI | 21.34 | |||||
| Price-to-Owner-Earnings | 22.56 | |||||
| PEG Ratio | 0.92 | |||||
| PS Ratio | 2.57 | |||||
| PB Ratio | 1.99 | |||||
| Price-to-Tangible-Book | 1.99 | |||||
| Price-to-Operating-Cash-Flow | 1357.62 | |||||
| EV-to-EBIT | 11.27 | |||||
| EV-to-EBITDA | 11.27 | |||||
| EV-to-Revenue | 1.75 | |||||
| EV-to-FCF | -268.46 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.85 | |||||
| Price-to-Graham-Number | 1.38 | |||||
| Price-to-Net-Current-Asset-Value | 2.06 | |||||
| Price-to-Net-Cash | 3.57 | |||||
| Earnings Yield (Greenblatt) % | 8.87 | |||||
| FCF Yield % | -0.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SMO Clinplus Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 809.886 | ||
| EPS (TTM) (Â¥) | 1.302 | ||
| Beta | 0 | ||
| Volatility % | 54.95 | ||
| 14-Day RSI | 38.94 | ||
| 14-Day ATR (Â¥) | 1.074121 | ||
| 20-Day SMA (Â¥) | 30.4595 | ||
| 12-1 Month Momentum % | -35.57 | ||
| 52-Week Range (Â¥) | 23.07 - 49.538461 | ||
| Shares Outstanding (Mil) | 79.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SMO Clinplus Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SMO Clinplus Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
SMO Clinplus Co Ltd Frequently Asked Questions
What is SMO Clinplus Co Ltd(SZSE:301257)'s stock price today?
The current price of SZSE:301257 is ¥28.58. The 52 week high of SZSE:301257 is ¥49.54 and 52 week low is ¥23.07.
When is next earnings date of SMO Clinplus Co Ltd(SZSE:301257)?
The next earnings date of SMO Clinplus Co Ltd(SZSE:301257) is .
Does SMO Clinplus Co Ltd(SZSE:301257) pay dividends? If so, how much?
The Dividend Yield %  of SMO Clinplus Co Ltd(SZSE:301257) is 0.96% (As of Today), Highest Dividend Payout Ratio of SMO Clinplus Co Ltd(SZSE:301257) was 0.13. The lowest was 0.09. And the median was 0.09. The  Forward Dividend Yield % of SMO Clinplus Co Ltd(SZSE:301257) is 1.15%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers